Navigation Links
Sperian Respiratory Protection USA Awarded a 65,000 Reusable Respirator Order by the Veterans Health Administration
Date:7/12/2010

SANTA ANA, Calif., July 12 /PRNewswire/ -- The U.S. Veterans Health Administration (VHA) has awarded Sperian Respiratory Protection USA a contract to purchase 65,000 special configuration modified Sperian Blue1 half-mask respirators with speaking diaphragm for use in VHA hospitals nationwide. VHA is the largest integrated healthcare system in the United States with over 150 hospitals and 130,000 healthcare workers.  This award is a result of Sperian's emphasis on developing respiratory products that enhance speech intelligibility when worn by healthcare workers.

Recent studies have underscored the difficulties of communicating when wearing respiratory equipment.  A study by The National Center for Occupational Health and Infection Control, Veterans Health Administration was published in the Journal of Occupational and Environmental Hygiene, "Diminished Speech Intelligibility Associated with Certain Types of Respirators Worn by Healthcare Workers"* focused on communication interference associated with various disposable and half-mask respirators on the market today.

The Institute of Medicine (IOM) had identified communication interference as a key issue to be studied in speech intelligibility. Communication interference is a concern with some respirators commonly used by U.S. healthcare workers.  The objective of the VHA study was to determine speech intelligibility and auditory clarity of respirators commonly worn in a healthcare setting as compared to Surgical Masks and no respiratory protective equipment.  Disposable, reusable and powered air purifying respirators (PAPR) were among those included in the study. The study looked at the percentage of words spoken and understood while the healthcare worker wore various types of respiratory protection devices.

Wearing half-face elastomeric respirators with voice augmentation equipment was associated with higher speech intelligibility than models without this equipment. The data shows a statistically significant difference in word intelligibility when comparing half-face elastomeric models equipped with and without speech augmentation devices.  The study concluded that this problem may be partially mitigated by wearing half-face elastomeric models with "speaking membranes," or voice augmentation devices that are associated with higher word intelligibility than those without such devices.  PAPR respirators produce noise that can interfere with the hearing capability of the wearer.  All respiratory protective devices were well tolerated for the duration of the study.

The Survivair Blue1 Half Mask with Speaking Diaphragm equipped with P100 Filters was among the highest rated and best performing reusable half mask respirator for speech tangibility.

The Survivair Blue1 with Speaking Diaghram is the only half-mask respirator available with a silicone, dual sealing flange skirt which offers a better sealing surface for keeping a tight seal and comfortable fit on healthcare workers. P100 Filters provide a 99.97% filtration efficiency. Special modifications were made to the standard Survivair Blue1 specifically for the needs of the healthcare market. Splash guards for P100 filters were designed to keep patients from contaminating the filters. A sweep back exhalation valve cover was also developed to divert a worker's exhaled breath away from the patient. These modifications created the Survivair Blue1 H-Version.

After analysis of the peculiar problems faced by healthcare workers, Sperian developed a modified half-mask product in a special configuration, packaged to meet the specific needs in the VHA. The Sperian H-Version Blue1 reusable elastomeric half-mask with Speaking Diaphragm provides the healthcare industry a single package that can be deployed to healthcare workers in a pandemic or when there is a shortage of disposable respirators.  The VHA configuration package contains a fully assembled Sperian Blue1 H-Version respirator ready for donning, and a set of replacement P100 filters.

Sperian's focus on the intimate relationship with its end users was instrumental in quickly adapting the product and changes to meet the needs and requests of the VHA.  Modification of the existing model required new NIOSH approval for the Sperian Blue1 H-Version.  Sperian's full respirator product design, test and manufacturing capabilities were deployed to obtain prompt NIOSH approval and ramp up production to meet delivery commitments.

For more information, check www.sperian.com or contact Vick Sarkissian, Sr. Product Manager, at Sperian Respiratory Protection USA, LLC, 3001 South Susan Street, Santa Ana, CA 92704. He can be phoned at 714 427 5204 or emailed at vsarkissian@sperian.com.

About Sperian Protection

With nearly 6,000 employees worldwide, Sperian Protection (formerly Bacou-Dalloz) is the world's leading manufacturer of personal protective equipment. Sperian's expertise focuses on head, body and fall protection products including; hearing, eye and respiratory protection, protective apparel, safety harnesses, belts, anchors and fall prevention systems.

* Radonovich Jr., Lewis J., Yanke, Robert, Cheng, Jing and Bender, Bradley (2009),'Diminished Speech Intelligibility Associated with Certain Types of Respirators Worn by Healthcare Workers', Journal of Occupational and Environmental Hygiene, 7: 1, 63-70, First Published on: 10 November 2009 (iFirst)


'/>"/>
SOURCE Sperian Respiratory Protection USA, LLC
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Study Results for Aclidinium Bromide, a Novel Anticholinergic, Presented at European Respiratory Society Annual Congress
2. NVA237 Phase II Results Presented at the European Respiratory Society Annual Meeting Show Promising Efficacy and Tolerability With Potentially Faster Onset Than Tiotropium
3. MedImmune Advances Pediatric Disease Prevention Program With Start of Phase 1/2a Clinical Trial for Respiratory Syncytial Virus Vaccine
4. Novavax Announces Preclinical Data for Respiratory Syncytial Virus Vaccine Candidate
5. Data from Phase 2 Study of Peramivir in Patients Hospitalized with Influenza Presented at the XI International Symposium on Respiratory Viral Infections
6. Researchers Find Common Respiratory Virus Hijacks Lung Cells to Stay Alive
7. QVA149 Phase II Data Presented at the European Respiratory Society Annual Meeting
8. PARI Respiratory Launches PEP S
9. Reportlinker Adds Global Anesthesia and Respiratory Devices Market Analysis and Forecasts to 2015
10. OxySure(R) Aids Student in School Respiratory Arrest: WFAA Channel 8 News
11. Reportlinker Adds Chinese Markets for Respiratory Drugs
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/23/2016)... , June 23, 2016 Any dentist who has ... of the current process. Many of them do not even ... technical difficulties and high laboratory costs involved. And those who ... it at such a high cost that the majority of ... Dr. Parsa Zadeh , founder of Dental Evolutions ...
(Date:6/23/2016)... Roche (SIX: RO, ROG; OTCQX: RHHBY) announced ... BRAHMS PCT (procalcitonin) assay as a dedicated testing solution ... this clearance, Roche is the first IVD company in ... sepsis risk assessment and management. PCT is ... levels in blood can aid clinicians in assessing the ...
(Date:6/23/2016)... Research and Markets has announced the addition of the ... offering. The current unmet ... for MedImmune to enter. The US ageing population creates a ... considerable growth for effective anti-influenza medications. The introduction of a ... development is still in its infancy. Key ...
Breaking Medicine Technology:
(Date:6/26/2016)... , ... June 26, 2016 , ... PawPaws brand ... new product that was developed to enhance the health of felines. The formula is ... The two main herbs in the PawPaws Cat Kidney Support Supplement Soft ...
(Date:6/25/2016)... D.C. (PRWEB) , ... June 25, 2016 , ... ... discuss health policy issues and applications at AcademyHealth’s Annual Research Meeting June 26-28, ... their work on several important health care topics including advance care planning, healthcare ...
(Date:6/25/2016)... (PRWEB) , ... June 25, 2016 , ... "With 30 ... their specific project," said Christina Austin - CEO of Pixel Film Studios. , ... and all within Final Cut Pro X . Simply select a ProHand generator ...
(Date:6/25/2016)... ... June 25, 2016 , ... Dr. Calvin Johnson has dedicated ... has implemented orthobiologic procedures as a method for treating his patients. The procedure ... doctors to perform the treatment. Orthobiologics are substances that orthopaedic surgeons use to ...
(Date:6/24/2016)... ... , ... A recent article published June 14 on E Online ... on to state that individuals are now more comfortable seeking to undergo not only ... calf and cheek reduction. The Los Angeles area medical group, Beverly Hills Physicians (BHP) ...
Breaking Medicine News(10 mins):